Notícias Denali Capital Acquisition Corporation - DECA | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Denali Capital Acquisition Corporation (DECA)
Denali Capital Acquisition Corporation (DECA) Notícias

Denali Capital Acquisition Corporation (DECA)

11,98

0,015

( 0,13% )

Atualizado: 13:42:50

Atrasado por 15 minutos

Seu centro para cotações em tempo real, discussões ao vivo e novas ideias.

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously

Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur a

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination

Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Denali Capital Acquisition

XFIG25 - Fevereiro 2025

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições